ARC
CLVS

Absolute Return Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Absolute Return Capital’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,431
Closed -$142K – 1009
2014
Q2 		$142K Sell
3,431
-8,210
-71% -$423K ﹤0.01% 1076
2014
Q1 		$806K Buy
+11,641
New +$855K 0.01% 696

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Absolute Return Capital's CLVS Position: Q3 2014 in Review

Absolute Return Capital sold out of Clovis Oncology, Inc. (CLVS) in Q3 2014, closing a stake of 3,431 shares — an estimated $142K sold.

Absolute Return Capital first reported a position in CLVS in Q1 2014 and held it in 2 quarters. The position peaked at $806K in Q1 2014. 138 funds tracked by Wall St. Rank hold CLVS as of Q3 2014.

  • Absolute Return Capital reported no remaining Clovis Oncology, Inc. position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 3,431 Clovis Oncology, Inc. shares in Q3 2014, an estimated $142K.
  • Absolute Return Capital first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 2 quarters.
  • Absolute Return Capital's Clovis Oncology, Inc. position peaked at $806K in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.